Pancreatic Cancer

Basser Center Genetic Counselor Jacquelyn Powers, MS, LCGC, discusses the basic of BRCA mutations in men and shares helpful information like associated cancer risk and typical screening recommendations.

The Basser Center’s virtual Breakthroughs and Discoveries panel brought together internationally renowned experts in the field of BRCA-related cancer research and care to discuss how discoveries in the lab translate to patient care.

Basser Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.

Basser Executive Director Susan Domchek, MD, discusses hereditary cancer risk for BRCA mutation carriers and ways in which that might impact individuals differently.

Basser Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

The Basser Center for BRCA's Executive Director, Susan Domchel, MD, sheds some light on BRCA mutations and hereditary cancer.

Germline genetic testing for cancer susceptibility is currently recommended for pancreatic cancer patients due to potential implications for targeted therapies and risk assessment of family members. This video was created in an effort to share existing resources and increase genetic testing rates in those with pancreatic cancer patients.